Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.

Phase 1 Active not recruiting 6 enrolled Xizang Haisco Pharmaceutical Co., Ltd

NaSingle-groupOpen-labelTreatment

Summary

This is a single-center, nonrandomized, and open design study to investigate the pharmacokinetics, mass balance, metabolism and excretion of HSK31858 in healthy male subjects.

Timeline

Start: 2024-05-30
Primary completion: 2024-07-02
Completion: 2024-10-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HSK31858	Unknown	40 mg	Oral

Indications

No indication recorded.